Steven G. Hughes
Chief Tech/Sci/R&D Officer presso AVIDITY BIOSCIENCES, INC.
Profilo
Steven G.
Hughes is currently the Chief Development Officer at Arcturus Therapeutics, Inc. and the Chief Medical Officer at Avidity Biosciences, Inc. He previously held positions as Medical Director-UK & Ireland at Biogen Idec Ltd., Chief Clinical Development Officer at Ionis Pharmaceuticals, Inc., Chief Medical Officer at Organovo Holdings, Inc., and Chief Development Officer at Arcturus Therapeutics Holdings, Inc. Hughes holds a doctorate from Imperial College London and an MBA from Imperial College Business School.
Posizioni attive di Steven G. Hughes
| Società | Posizione | Inizio |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 23/02/2022 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 02/01/2020 |
Precedenti posizioni note di Steven G. Hughes
| Società | Posizione | Fine |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Chief Tech/Sci/R&D Officer | 14/02/2022 |
| ORGANOVO HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | - |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Corporate Officer/Principal | - |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Steven G. Hughes
| Imperial College London | Doctorate Degree |
| Imperial College Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ORGANOVO HOLDINGS, INC. | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Health Technology |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Steven G. Hughes
